Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Stein

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Antisense & Nucleic Acid Drug Development|June 1, 1997
Controversies in the cellular pharmacology of oligodeoxynucleotidesC A Stein
Antisense & Nucleic Acid Drug Development|May 21, 1998
How to design an antisense oligodeoxynucleotide experiment: a consensus approachC A Stein
Biochimica Et Biophysica Acta|May 12, 2000
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experimentsC A Stein
Nature Biotechnology|March 30, 1999
Keeping the biotechnology of antisense in contextC A Stein
The Journal of Clinical Investigation|September 7, 2001
The experimental use of antisense oligonucleotides: a guide for the perplexedC A Stein
Nature Medicine|November 1, 1995
Does antisense exist?C A Stein
Ciba Foundation Symposium|January 1, 1997
Controversies in the cellular pharmacology of oligodeoxynucleotidesC A Stein
Nature Biotechnology|August 2, 2001
Antisense that comes naturallyC A Stein
Journal of Bioenergetics and Biomembranes|July 26, 2008
Specific VDAC inhibitors: phosphorothioate oligonucleotidesC A Stein, Marco Colombini
Molecular Cancer Therapeutics|December 20, 2002
Antisense oligonucleotides: basic concepts and mechanismsNathalie Dias, C A Stein
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Antisense & Nucleic Acid Drug Development|June 1, 1997
Controversies in the cellular pharmacology of oligodeoxynucleotidesC A Stein
Antisense & Nucleic Acid Drug Development|May 21, 1998
How to design an antisense oligodeoxynucleotide experiment: a consensus approachC A Stein
Biochimica Et Biophysica Acta|May 12, 2000
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experimentsC A Stein
Nature Biotechnology|March 30, 1999
Keeping the biotechnology of antisense in contextC A Stein
The Journal of Clinical Investigation|September 7, 2001
The experimental use of antisense oligonucleotides: a guide for the perplexedC A Stein
Nature Medicine|November 1, 1995
Does antisense exist?C A Stein
Ciba Foundation Symposium|January 1, 1997
Controversies in the cellular pharmacology of oligodeoxynucleotidesC A Stein
Nature Biotechnology|August 2, 2001
Antisense that comes naturallyC A Stein
Journal of Bioenergetics and Biomembranes|July 26, 2008
Specific VDAC inhibitors: phosphorothioate oligonucleotidesC A Stein, Marco Colombini
Molecular Cancer Therapeutics|December 20, 2002
Antisense oligonucleotides: basic concepts and mechanismsNathalie Dias, C A Stein
Pageof 16